Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Neuropharmacology. 2019 Feb 11;149:83–96. doi: 10.1016/j.neuropharm.2019.02.005

Table 1. Binding affinities of mGlu5 allosteric ligands derived from inhibition of [3H]methoxy-PEPy binding in intact and adherent HEK293A-rat mGlu5-low cells and mouse cortical neurons.

Data represent mean ± SEM of 3–6 independent experiments performed in duplicate.

HEK293A-rat mGlu5-low pKB Mouse cortical neurons pKB
High Low Fraction High Logα High Low Fraction High Logα
MPEP 8.26 ±0.23 6.25 ±0.11 0.62 ±0.11 n.a. 8.38 ±0.30 5.92 ±0.20 0.73 ±0.11 n.a.
fenobam 7.15 ±0.28 4.66 ±0.22 0.71 ±0.09 n.a. 7.53 ±0.37a n.a. 1a −0.66 ±0.10
VU0409106 7.47 ±0.07 n.a. 1 −1.12 ±0.12 7.48 ±0.15 n.a. 1 −0.78 ±0.13
VU0366248 6.94 ±0.13 n.a. 1 −0.77 ±0.06 6.72 ±0.06 n.a. 1 −0.54 ±0.06
VU0366058 7.26 ±0.10 n.a. 1b −0.82 ±0.07 6.76 ±0.23 n.a. 1b −0.71 ±0.07
M-5MPEP 7.13 ±0.07 n.a. 1 n.a. 6.43 ±0.25 n.a. 1 n.a.
dipraglurant 7.31 ±0.11 n.a. 1 −1.24 ±0.17 6.98 ±0.14 n.a. 1 −0.89 ±0.08
MTEP 7.20 ±0.28 5.45 ±0.30 0.83 ±0.04 n.a. 8.16 ±0.14* 6.09 ±0.45 0.74 ±0.04 n.a.
a

One individual experiment (from n=6) was best fitted to a two-site binding curve (F test p>0.05).

b

Two individual experiments (from n=5–6) were best fitted to a two-site binding curve.

*

Denotes p<0.05, One-way ANOVA, Sidak’s multiple comparisons test, compared to HEK293A-rat mGlu5-low

n.a. not applicable due to one-site or competitive binding curve fit